Filing identity and reporting period
The supplied filing is an unaudited Form 10-Q for Ecology Coatings, Inc., covering the three months ended December 31, 2012, with comparison to the three months ended December 31, 2011. This conflicts with the request metadata identifying ABVC Biopharma, Inc. and 2013 Q1. The report was signed April 16, 2015. The filing states the company later filed for Chapter 7 bankruptcy in May 2013 and emerged in September 2014 with its corporate shell as its only asset; these operating results therefore describe a business that no longer existed in that form.
Financial performance and condition
| Metric | Three months ended Dec. 31, 2012 | Prior comparable period |
|---|---|---|
| Revenue | $7,026 | $2,049 |
| Operating expenses | $144,460 | $461,026 |
| Operating loss | $(137,434) | $(458,977) |
| Interest expense | $(16,369) | $(46,964) |
| Net loss | $(153,803) | $(277,139) |
| Net loss available to common shareholders | $(157,151) | $(468,911) |
| Basic and diluted loss per share | $(0.00) | $(0.03) |
| Net cash used in operations | $(36,350) | $(366,630) |
| Cash at period end | $2,036 | $30,197 |
Revenue came from one customer. Gross profit and gross margin are not separately presented. No income-tax expense or benefit was recorded. At December 31, 2012, current assets were $25,774 and current liabilities were $2,066,722, implying a working-capital deficit of approximately $2.04 million. Current liabilities included $1,138,501 in related-party notes, $604,330 in judgment payable, $151,121 in interest payable, and $164,958 in accounts payable and accrued expenses. The balance sheet reports total assets of $271,793 and total liabilities and equity of $265,793, which do not reconcile.
Changes versus the prior comparable period
- Revenue increased by $4,977, but remained very small and dependent on a single customer.
- Operating expenses fell by about $316,566, which management attributed to reduced staffing and lower professional fees. Operating loss narrowed substantially.
- Net loss improved by $123,336 based on the statements of operations. The prior period included $228,802 of debt-forgiveness income, while current-period interest expense was lower.
- Operating cash use declined, but cash fell from $13,386 at September 30, 2012 to $2,036 at December 31, 2012. The company reported $25,000 of note payments in financing activities.
Outlook, risks, contingencies, and unusual items
- The filing provides no quantified forward guidance. Management identified commercialization, financing, profitability, competition, intellectual property, manufacturing, supplier, and personnel risks.
- Management disclosed going-concern uncertainty, operating losses, working-capital deficits, negative operating cash flow, and insufficient cash. It also reported that liabilities exceeded assets by approximately $1.9 million and that the company subsequently entered Chapter 7.
- A $604,330 judgment arose from litigation by noteholder Mitch Shaheen. The filing also lists three promissory notes in default at December 31, 2012, with amounts owing of $2,584, $166,173, and $138,055.
- Disclosure controls were deemed ineffective due to inadequate segregation of financial-reporting duties in the small staff. The company marked that it had not filed all required reports during the preceding 12 months.
- There are internal inconsistencies in the filing: management's discussion describes the net-loss decrease as approximately $311,000, unlike the $123,336 change in the statements; the balance-sheet totals do not balance; and share counts and period references in the filing conflict in places.
Most important facts to verify
- Confirm the issuer and period: the supplied filing is Ecology Coatings, Inc. for the quarter ended December 31, 2012, not ABVC Biopharma for 2013 Q1.
- Reconcile balance-sheet totals, reported share counts, and the difference between management's stated and tabular net-loss comparisons.
- Verify the bankruptcy outcome and the stated settlement/discharge of liabilities, including the September 2014 fresh-start treatment.
- Assess the status and recoverability of assets, the judgment and defaulted notes, and any remaining obligations after bankruptcy.
- Consider the single-customer revenue concentration, extremely limited cash, ineffective disclosure controls, and late filing when evaluating the historical financial information.